Mark Roschewski

Also affiliated with Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.424Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.03.494716

Top 44%

0.424DataRank

Top 44%7 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +33 more

Papers

Driven by 35 papers — median percentile 56. Top paper: “Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma”.

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of Clinical Oncology(2020)10.1200/jco.20.00303

N/A

5.0DataRank · unranked

152 citations

Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti A. Patel +19 more

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Blood(2022)10.1182/blood.2021014738

N/A

4.5DataRank · unranked

141 citations

Jörg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst +22 more

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3971

N/A

1.3DataRank · unranked

45 citations

Elizabeth Hill, Alexander Dew, Candis Morrison, Joseph Roswarski, Neha Korde +29 more

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006397

N/A

1.3DataRank · unranked

44 citations

Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle S. Saba, Liza Lindenberg +11 more

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-019-0737-3

N/A

0.865DataRank · unranked

318 citations

Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi +15 more

Next-Generation Sequencing-Based Monitoring of Circulating Tumor DNA Reveals Clonotypic Heterogeneity in Untreated PTCL

Blood Advances(2021)10.1182/bloodadvances.2020003679

N/A

0.828DataRank · unranked

22 citations

Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Andrea N. Lucas, Allison P. Jacob +5 more

Artificial Intelligence in Lymphoma PET Imaging

PET Clinics(2021)10.1016/j.cpet.2021.09.006

N/A

0.601DataRank · unranked

54 citations

Sriram S. Paravastu, Faraz Farhadi, Fereshteh Yousefirizi, Michael Morris, Arman Rahmim +4 more

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-20-0009

N/A

0.584DataRank · unranked

48 citations

Alina Nicolae, George W. Wright, Christopher Melani, Mark Roschewski, Seth M. Steinberg +5 more

BTK drives neutrophil activation for sterilizing antifungal immunity

Journal of Clinical Investigation(2024)10.1172/jci176142

N/A

0.510DataRank · unranked

29 citations

Marissa A. Zarakas, Andrew Wishart, Mark Roschewski, Mariano A. Aufiero, Ágnes Donkó +23 more

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00029-7

N/A

0.493DataRank · unranked

14 citations

Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y. Song +11 more

A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.03.494716

Top 44%

0.424DataRank

Top 44%7 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +33 more

Preventing central nervous system spread in diffuse large B-cell lymphoma – novel approaches needed

Haematologica(2021)10.3324/haematol.2021.278559

N/A

0.360DataRank · unranked

10 citations

Mark Roschewski

Phased variants improve DLBCL minimal residual disease detection at the end of therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7565

N/A

0.348DataRank · unranked

3 citations

Jacob J. Chabon, Joanne Soo, Lyron Co Ting Keh, Stefan Alig, André Schultz +15 more

Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2413372121

N/A

0.330DataRank · unranked

8 citations

Frances A. Tosto, Xiaohu Zhang, Christopher Melani, Mark Roschewski, Erin Beck +13 more

The anti‐CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B‐cell lymphomas

British Journal of Haematology(2025)10.1111/bjh.20219

N/A

0.241DataRank · unranked

4 citations

Christopher Melani, Stefania Pittaluga, Max J. Gordon, James D. Phelan, Jagan Muppidi +7 more

Minimal residual disease guided treatment approaches in non-Hodgkin lymphoma—Where we are and where we’re headed

Seminars in Hematology(2025)10.1053/j.seminhematol.2026.02.003

N/A

0.241DataRank · unranked

4 citations

Mark Roschewski, Rahul Lakhotia

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00412

N/A

0.165DataRank · unranked

2 citations

Xiaohu Zhang, Patricia Alfonso, Patrick J. Morris, Carleen Klumpp‐Thomas, Christopher Melani +12 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Blood Neoplasia(2024)10.1016/j.bneo.2024.100054

N/A

0.165DataRank · unranked

2 citations

Sigrid Dubois, Miloš D. Miljković, Samuel Y. Ng, Bonita R. Bryant, Rahul Lakhotia +8 more

Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)

Hematological Oncology(2023)10.1002/hon.3164_437

N/A

0.104DataRank · unranked

1 citations

Rahul Lakhotia, Stefania Pittaluga, J. D. Phelan, Y. Yang, Theresa Davies‐Hill +17 more

Acute Transient Aminotransferase Elevation is Common With Intrathecal Methotrexate, but Liver Injury is Infrequent

Liver International(2025)10.1111/liv.70022

N/A

0DataRank · unranked

2 citations

Julian Hercun, Nirali N. Shah, Mark Roschewski, Yaron Rotman, Harish Gopalakrishna

Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma

The Cancer Journal(2020)10.1097/ppo.0000000000000450

N/A

0DataRank · unranked

54 citations

James D. Phelan, Wyndham H. Wilson, Mark Roschewski

Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-020-0864-x

N/A

0DataRank · unranked

4 citations

Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi +15 more

CAR T-Cell Therapy for Large B-Cell Lymphoma — Who, When, and How?

New England Journal of Medicine(2021)10.1056/nejme2118899

N/A

0DataRank · unranked

70 citations

Dan L. Longo, Wyndham H. Wilson, Mark Roschewski

CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.2002317

N/A

0DataRank · unranked

12 citations

Alba Navarro, Delong Liu, Sarah E. M. Herman, Shih‐Sung Chuang, Irma Slavutsky +9 more

Malignancy in STAT3 Deficient Hyper IgE Syndrome

Journal of Clinical Immunology(2022)10.1007/s10875-021-01197-y

N/A

0DataRank · unranked

8 citations

Christopher Melani, Mark Roschewski, Wyndham H. Wilson, Stefania Pittaluga, Haig Tcheurekdjian +4 more

SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2022)10.1016/j.clml.2022.06.002

N/A

0DataRank · unranked

4 citations

Mark Roschewski, Jillian Simard

Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma

Seminars in Nuclear Medicine(2023)10.1053/j.semnuclmed.2022.11.003

N/A

0DataRank · unranked

29 citations

Faraz Farhadi, Navid Hasani, Moozhan Nikpanah, Mark Roschewski, Ronald M. Summers +2 more

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas

Blood Advances(2023)10.1182/bloodadvances.2023011997

N/A

0DataRank · unranked

5 citations

Joseph G. Schroers‐Martin, Brian J. Sworder, Karan R. Kathuria, Stefan Alig, Matthew J. Frank +8 more

Clinical applications of circulating tumor DNA in indolent B-cell lymphomas

Seminars in Hematology(2023)10.1053/j.seminhematol.2023.06.003

N/A

0DataRank · unranked

4 citations

Mark Roschewski, Rahul Lakhotia

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Blood Advances(2023)10.1182/bloodadvances.2023010223

N/A

0DataRank · unranked

0 citations

Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani +10 more

EXABS-137-LYM Circulating Tumor DNA In Lymphoma: When Will It Be Ready for Prime Time?

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/s2152-2650(23)00299-9

N/A

0DataRank · unranked

0 citations

Mark Roschewski

Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients

Cancer Cell(2024)10.1016/j.ccell.2024.02.001

N/A

0DataRank · unranked

64 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +36 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Maryland Shared Open Access Repository (USMAI Consortium)(2024)10.13016/m2trio-fqf2

N/A

0DataRank · unranked

0 citations

Sigrid Dubois, Miloš Miljkovi?, Samuel Y. Ng, Bonita R Bryant, Rahul Lakhotia +8 more

Enitociclib ( VIP152 ), venetoclax and prednisone in relapsed or refractory aggressive non‐Hodgkin lymphoma

British Journal of Haematology(2025)10.1111/bjh.70234

N/A

0DataRank · unranked

1 citations

Rahul Lakhotia, Stefania Pittaluga, Svetlana Pack, Anna Marie Juanitez, Ahmed Hamdy +8 more

Mark Roschewski

Indexed papers

Top data-sharing exemplar

Papers